Factors associated with anemia in patients with cancer admitted to an intensive care unit

被引:3
作者
Cardenas-Turanzas, Marylou [1 ]
Cesta, Mark A. [2 ]
Wakefield, Chris
Wallace, Susannah Kish [3 ]
Puana, Rudolph
Price, Kristen J.
Nates, Joseph L.
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Crit Care Med, Div Anesthesiol Pain & Crit Care, Houston, TX 77030 USA
[2] Emergency Hlth Ctr Willowbrook, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Med Informat, Houston, TX 77030 USA
关键词
Anemia; Cancer; Prevalence; Risk factors; Intensive care unit; FAILURE ASSESSMENT SCORE; ORGAN DYSFUNCTION/FAILURE; SOFA SCORE;
D O I
10.1016/j.jcrc.2009.02.004
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Purpose: The study aimed to evaluate the relative impact of clinical and demographic factors associated with the prevalence and incidence of anemia (hemoglobin [Hb] <12 g/dL) in critically ill patients with cancer. Materials and Methods: We performed an electronic chart review for demographic and clinical data of adult patients with cancer with or without anemia admitted to the intensive care unit (ICU). Prevalence of anemia was determined at admission, and incidence determined if anemia developed during ICU stay. Anemia was classified as mild, moderate, or severe. The additive impact of clinical and demographic factors was evaluated by using a hierarchical linear regression model. Results: A total of 4705 patients were included in the study. The prevalence and incidence of anemia were 68.0% and 46.6%, respectively. In prevalent cases, we found that the clinical covariates modified sequential organ failure assessment score, admission to the medical ICU, prior chemotherapy, diagnosis of hematologic cancer, and length of hospital stay before ICU admission explained 18.7% of the variance in the model, whereas the demographic covariates (age, sex, and race) explained only an additional 0.6%. The pattern was similar for incidence cases. Conclusions: Clinical factors are more influential than demographic factors in the observed rates of prevalence and incidence of anemia in the ICU; thus, protocols are needed to identify subgroups of patients with cancer who could benefit from novel management strategies. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:112 / 119
页数:8
相关论文
共 24 条
[1]  
[Anonymous], 2006, Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0
[2]  
Caro JJ, 2001, CANCER-AM CANCER SOC, V91, P2214, DOI 10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO
[3]  
2-P
[4]  
Catalano L, 1996, HAEMATOLOGICA, V81, P324
[5]   Anemia and blood transfusion in the critically ill patient: role of erythropoietin [J].
Corwin, HL .
CRITICAL CARE, 2004, 8 (Suppl 2) :S42-S44
[6]   Serial evaluation of the SOFA score to predict outcome in critically ill patients [J].
Ferreira, FL ;
Bota, DP ;
Bross, A ;
Mélot, C ;
Vincent, JL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (14) :1754-1758
[7]  
Glaspy J, 2001, CANCER-AM CANCER SOC, V92, P1719, DOI 10.1002/1097-0142(20010915)92:6+<1719::AID-CNCR1503>3.0.CO
[8]  
2-5
[9]  
Grossi Alberto, 2007, Ther Clin Risk Manag, V3, P269, DOI 10.2147/tcrm.2007.3.2.269
[10]   Anaemia of cancer: an overview of mechanisms involved in its pathogenesis [J].
Grotto, H. Z. W. .
MEDICAL ONCOLOGY, 2008, 25 (01) :12-21